drugset / Trial / NCT00241670

Fluorescence-guided Resection of Malignant Gliomas With 5-Aminolevulinic Acid

NCT00241670

Phase 3 Completed 415 enrolled medac GmbH
RandomizedParallel-groupSingle-blindDiagnostic

Summary

The aim of the study "Fluorescence-guided resection of malignant gliomas with 5-Aminolevulinic acid (5-ALA) vs. conventional resection" is to determine how accurately contrast agent-accumulating tumour can be removed by primary surgery and to assess the clinical usefulness of this method.

Timeline

Start
1999-10
Primary completion
2004-07
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Aminolevulinic Acid Diagnostic / imaging agent 1.5 g Oral